Q3 2023 Holdings
Filed 2023-11-14 | 46 holdings | $149.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $12.1M | 3,827,926 | 8.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $9.3M | 244,484 | 6.2% |
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $9.0M | 1,849,402 | 6.0% |
| Praxis Precision Medicines I | COM | 74006W108 | $7.7M | 4,485,000 | 5.1% |
| Rayzebio Inc | COM | 75525N107 | $7.6M | 344,571 | 5.1% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $7.6M | 550 | 5.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $7.4M | 362,000 | 5.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $7.1M | 205,377 | 4.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $6.5M | 138,198 | 4.4% |
| Kura Oncology Inc.(KURA) | COM | 50127T109 | $6.4M | 702,093 | 4.3% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $6.2M | 418,000 | 4.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.2M | 121,022 | 4.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $5.0M | 129,000 | 3.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $4.3M | 297,035 | 2.9% |
| Hillevax Inc | COM | 43157M102 | $3.6M | 270,319 | 2.4% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $3.5M | 126,500 | 2.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $3.4M | 224,339 | 2.3% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $3.4M | 122,341 | 2.3% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $2.8M | 94,000 | 1.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $2.8M | 555,260 | 1.9% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $2.6M | 150,000 | 1.7% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $2.4M | 300,128 | 1.6% |
| Ikena Oncology Inc | COM | 45175G108 | $2.4M | 551,010 | 1.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.1M | 323,349 | 1.4% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $1.9M | 153,007 | 1.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $1.9M | 15,500 | 1.3% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.9M | 230,000 | 1.3% |
| Replimune Group Inc(REPL)Call | COM | 76029N106 | $1.8M | 1,000 | 1.2% |
| 89Bio Inc(ETNBGBP)Call | COM | 282559103 | $1.5M | 1,000 | 1.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $1.4M | 103,600 | 0.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.3M | 146,500 | 0.9% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $934.4K | 718,739 | 0.6% |
| Aclaris Therapeutics(ACRS) | COM | 00461U105 | $833.6K | 121,692 | 0.6% |
| Brainstorm Cell Therapeutics(BCLIEUR)Put | COM NEW | 10501E201 | $825.0K | 2,500 | 0.6% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $549.5K | 39,935 | 0.4% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $512.6K | 11,300 | 0.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $506.4K | 32,800 | 0.3% |
| Leap Therapeutics Inc(CYPH) | COM NEW | 52187K200 | $488.7K | 354,166 | 0.3% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $409.2K | 310,000 | 0.3% |
| Cellectar Biosciences Inc.(CLRBUSD) | COM NEW | 15117F807 | $320.2K | 121,300 | 0.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $252.1K | 5,000 | 0.2% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $213.9K | 13,300 | 0.1% |
| Marinus Pharmeceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $157.0K | 19,500 | 0.1% |
| Mersana Therapeutics Inc | COM | 59045L106 | $126.5K | 99,607 | 0.1% |
| Glycomimetic Inc(GLYCEUR) | COM | 38000Q102 | $41.3K | 27,500 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $9.1K | 90,832 | 0.0% |